Wellington Management Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-109,495
Closed -$714K 1948
2024
Q2
$714K Buy
109,495
+14,401
+15% +$93.9K ﹤0.01% 1729
2024
Q1
$828K Sell
95,094
-2,324
-2% -$20.2K ﹤0.01% 1718
2023
Q4
$1.11M Buy
+97,418
New +$1.11M ﹤0.01% 1607
2023
Q2
Sell
-6,178,438
Closed -$65M 1902
2023
Q1
$65M Sell
6,178,438
-7,161,939
-54% -$75.3M 0.01% 636
2022
Q4
$165M Sell
13,340,377
-517,692
-4% -$6.41M 0.03% 423
2022
Q3
$144M Sell
13,858,069
-1,059,885
-7% -$11M 0.03% 437
2022
Q2
$172M Sell
14,917,954
-263,693
-2% -$3.04M 0.03% 414
2022
Q1
$191M Sell
15,181,647
-2,118,658
-12% -$26.7M 0.03% 427
2021
Q4
$202M Sell
17,300,305
-200,716
-1% -$2.34M 0.03% 444
2021
Q3
$229M Sell
17,501,021
-3,593,630
-17% -$46.9M 0.04% 408
2021
Q2
$271M Sell
21,094,651
-94,654
-0.4% -$1.22M 0.05% 375
2021
Q1
$237M Sell
21,189,305
-428,408
-2% -$4.79M 0.04% 389
2020
Q4
$246M Sell
21,617,713
-657,441
-3% -$7.49M 0.05% 364
2020
Q3
$200M Buy
22,275,154
+56,295
+0.3% +$506K 0.04% 363
2020
Q2
$229M Buy
22,218,859
+154,589
+0.7% +$1.6M 0.05% 322
2020
Q1
$223M Buy
22,064,270
+340,598
+2% +$3.44M 0.06% 273
2019
Q4
$289M Sell
21,723,672
-3,490
-0% -$46.5K 0.06% 306
2019
Q3
$187M Sell
21,727,162
-541
-0% -$4.65K 0.04% 401
2019
Q2
$238M Sell
21,727,703
-4,060,105
-16% -$44.4M 0.05% 330
2019
Q1
$292M Buy
25,787,808
+2,445,895
+10% +$27.7M 0.07% 286
2018
Q4
$203M Buy
23,341,913
+138,747
+0.6% +$1.2M 0.05% 331
2018
Q3
$359M Buy
23,203,166
+202,825
+0.9% +$3.14M 0.08% 261
2018
Q2
$368M Buy
23,000,341
+156,936
+0.7% +$2.51M 0.08% 253
2018
Q1
$295M Buy
22,843,405
+251,975
+1% +$3.26M 0.07% 291
2017
Q4
$284M Buy
22,591,430
+48,487
+0.2% +$609K 0.06% 293
2017
Q3
$298M Buy
22,542,943
+167,754
+0.7% +$2.22M 0.07% 271
2017
Q2
$354M Buy
22,375,189
+188,814
+0.9% +$2.99M 0.08% 240
2017
Q1
$317M Buy
22,186,375
+296,725
+1% +$4.24M 0.08% 249
2016
Q4
$280M Buy
21,889,650
+181,349
+0.8% +$2.32M 0.07% 253
2016
Q3
$289M Buy
21,708,301
+243,251
+1% +$3.24M 0.07% 256
2016
Q2
$235M Buy
21,465,050
+160,121
+0.8% +$1.75M 0.06% 280
2016
Q1
$195M Buy
21,304,929
+77,746
+0.4% +$712K 0.05% 320
2015
Q4
$206M Buy
21,227,183
+90,336
+0.4% +$877K 0.05% 309
2015
Q3
$184M Buy
21,136,847
+89,573
+0.4% +$782K 0.05% 317
2015
Q2
$213M Buy
21,047,274
+117,410
+0.6% +$1.19M 0.05% 307
2015
Q1
$280M Buy
20,929,864
+286,529
+1% +$3.84M 0.07% 266
2014
Q4
$265M Buy
20,643,335
+439,296
+2% +$5.64M 0.07% 273
2014
Q3
$219M Buy
20,204,039
+231,458
+1% +$2.51M 0.06% 303
2014
Q2
$256M Buy
19,972,581
+98,980
+0.5% +$1.27M 0.07% 300
2014
Q1
$205M Buy
19,873,601
+3,604,962
+22% +$37.2M 0.06% 339
2013
Q4
$158M Buy
16,268,639
+334,772
+2% +$3.26M 0.05% 400
2013
Q3
$158M Buy
15,933,867
+175,233
+1% +$1.74M 0.05% 378
2013
Q2
$131M Buy
+15,758,634
New +$131M 0.04% 399